510(k) device
GyroStim
Ultrathera Technologies, Inc. · Apparatus, Vestibular Analysis (LXV, Unclassified) · First FDA decision Apr 27, 2022, newest Apr 27, 2022
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
2
Naming "GyroStim"
MAUDE reports
1
Brand "GyroStim", since 2015
PubMed studies
0
Mentioning "GyroStim"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- GyroStimBreakthrough510(k)
K220231 · Decided Apr 27, 2022 · 90 days after receipt
Device type: Apparatus, Vestibular Analysis (LXV) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "GyroStim", any status and sponsor, newest update first.
- GyroStim for Post Concussion SyndromeRecruiting
Neuroscience GroupAcademic, hospital or other
NCT07527663 · 128 participants (planned) · Start Mar 16, 2026 · Primary completion Sep 30, 2027
Device: Sensorimotor Multi-axis Automated Rotational Therapy (SMART) utilizing GyroStim device · For: Post Concussion Syndrome
Sites: Appleton, Wisconsin
Carrick Institute for Graduate StudiesAcademic, hospital or other
NCT01188161 · 25 participants · Start Jul 2010 · Primary completion Aug 2010
Device: Rotating Chair · For: Falls; Balance; Movement Disorders
Sites: Marietta, Georgia
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "GyroStim", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code LXV
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
- GYROSTIMInjury
MW5062224 · Received Mar 29, 2016 · Event dated Nov 4, 2014
Device type: Stimulator, Vestibular Acceleration, Therapeutic (MHZ)
Device problem as coded: Mechanical Problem; Failure to Shut Off
Patient problem as coded: Fatigue; Neurological Deficit/Dysfunction
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "GyroStim"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LXV.
- OrionInteracoustics A/S · 510(k) 2020
- TrvInteracoustics A/S · 510(k) 2020
- ClearEdge Balance SystemQuadrant Biosciences · 510(k) 2019
- EQ BalanceUpright Science, Inc. · 510(k) 2019
- K-D BalanceKing-Devick Technologies, Inc. · 510(k) 2018
- Vestibular Analysis ApparatusCapacity Sports, LLC · 510(k) 2012
- Nydiag 200Interacoustics A/S · 510(k) 2010
- Vertigone Bppv GoggleVertigone, Inc. · 510(k) 2009
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.